Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.37 | 16.26 |
| PEG Ratio (TTM) | 1.81 | 1.57 |
| P/S Ratio (TTM) | 0.82 | 2.62 |
| P/B Ratio (TTM) | 0.90 | 1.90 |
| P/FCF Ratio (TTM) | 26.40 | 11.27 |
| Price to 5YR AVG Earnings Ratio | 7.64 | 14.29 |
| Price to 5YR AVG FCF Ratio | 7.04 | 8.15 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.47% | 1,525.79% |
| ROE (TTM) | 6.99% | 8.86% |
| Net Profit Margin (TTM) | 6.05% | 15.64% |
| ROIC 5YR AVG | 11.32% | 20.60% |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 86.95% | 75.07% | 30.66% |
| Revenue | 21.78% | 40.15% | 28.99% |
| Net Income | 87.65% | 71.75% | 27.45% |
| Cash Flow | 3,227.74% | -177.74% | -134.82% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.11 | 3.16 |
| Quick Ratio (TTM) | 0.11 | 4.79 |
| D/E Ratio (TTM) | 1.16 | 1.26 |
| Interest Coverage (TTM) | 1.08 | 0.63 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 0.10 | 0.38 |
| LTL to 5YR AVG FCF | 3.86 | 6.30 |
| Shares Outstanding Growth 5YR AVG | -2.75% | 4.79% |